National Health Investors price to sales ratio NHI

Market value divided by revenue over the last twelve months, since 2011.

Today, Oct 23, 2026: 7.6×
10-year median: 9.8×
Against its 10-year history: 7th; percentile: 0 is its lowest day, 100 its highest
10-year range: 5.3× to 12.7×
Peer median: 4.5×

National Health Investors' price to sales ratio is 7.6× as of Oct 23, 2026.

That is below its ten-year median of 9.8×, lower than on 93% of days in the last ten years.

Over that time it ranged from 5.3× in Apr 2020 to 12.7× in Feb 2020.

The median for 10 specialty REITs of a similar size is 4.5×.

Price to sales ratio over time

median 9.8×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	7.6×	7.4×	12.0×
2025	10.3×	9.1×	10.9×
2024	9.5×	7.4×	11.3×
2023	7.8×	6.9×	9.3×
2022	8.2×	7.9×	10.8×
2021	8.5×	7.5×	10.3×
2020	9.3×	5.3×	12.7×
2019	11.7×	10.9×	12.2×
2018	10.9×	9.8×	11.6×
2017	11.5×	11.1×	12.7×
2016	12.2×	9.8×	13.3×
2015	10.6×	9.7×	15.4×
2014	14.1×	12.6×	17.4×
2013	13.7×	13.7×	19.8×
2012	16.7×	15.1×	17.5×
2011	15.2×	14.1×	16.6×

Against its peers

Companies in REIT - Specialty nearest National Health Investors' size, closest first, today.

Company	Price to sales ratio
NHINational Health Investors	7.6×
BNLBroadstone Net Lease	7.0×
HIWHighwoods Properties	4.0×
IRTIndependence Realty Trust	5.3×
LXPLXP Industrial Trust	10.4×
CXWCoreCivic	1.2×
CDPCopt Defense Properties	4.9×
DRHDiamondRock Hospitality	2.5×
DXDynex Capital	n/m
HHHHoward Hughes	1.8×
AKRAcadia Realty Trust	n/m
Peer median	4.5×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on National Health Investors

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.